Almoosa Health: Q3 Loss Driven by Non-Cash Accounting Impact of Derivative Valuation, While Core Operations Remain Profitable and Expansion Plans Stay on Track

Almoosa Health Company reported a non-cash loss of SAR 81.9 million in the third quarter of 2026, resulting from the mark-to-market (MTM) valuation of ...

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.argaam.com)